PGM5-AS1: A Potential Drug Target and Biomarker (G572558)

Target Name: PGM5-AS1

NCBI ID: G572558

PGM5-AS1

Other Name(s): PGM5 antisense RNA 1 | FAM233A | PGM5-AS1 variant 3

PGM5-AS1: A Potential Drug Target and Biomarker

Post-translational modification (PTM) is a process by which proteins are modified after their synthesis, but before they become functional. One of the most common PTMs is poly(A) tail, which is a short RNA molecule that is added to the 3 ' end of some proteins. These PTMs play a crucial role in cellular signaling and are involved in many important cellular processes, including cell division, apoptosis, and immune response.

One of the well-known PTMs is PGM5-AS1, which is a poly(A) tail RNA molecule that is added to the 3' end of the protein PGM5. PGM5 is a non-coding RNA molecule that is expressed in many tissues and is involved in the regulation of cellular processes such as cell growth, differentiation, and inflammation. PGM5-AS1 has been identified as a potential drug target and biomarker due to its unique structure and function.

PGM5-AS1 is a small RNA molecule that is approximately 200 nucleotides in length. It consists of a 5' end that is modified with a poly(A) tail, as well as a 3' end that is free. The poly(A )tail is a stable RNA molecule that is often used as a carrier for proteins to access RNA-protein binding sites. The 3' end of PGM5-AS1 is a variable length and can vary depending on the length of the PGM5 protein it is associated with.

The role of PGM5-AS1 in cellular signaling is not well understood, but it is believed to play a key role in the regulation of cell growth and differentiation. PGM5-AS1 has been shown to be involved in the regulation of cell cycle progression, and it has been shown to interact with several cellular signaling pathways, including the TGF-β pathway.

In addition to its role in cell signaling, PGM5-AS1 is also a potential biomarker for several diseases. For example, PGM5-AS1 has been shown to be overexpressed in several types of cancer, including breast, ovarian, and colorectal cancer. This suggests that PGM5-AS1 may be a useful biomarker for these diseases.

Another potential use of PGM5-AS1 as a drug target is its role in the regulation of inflammation. PGM5 has been shown to be involved in the regulation of inflammatory responses and has been shown to play a role in the regulation of pro-inflammatory cytokines. Therefore, PGM5-AS1 may be a potential drug target for the treatment of inflammatory diseases.

In conclusion, PGM5-AS1 is a unique and promising molecule that has the potential to be a drug target and biomarker. Further research is needed to fully understand its role in cellular signaling and its potential as a drug.

Protein Name: PGM5 Antisense RNA 1

The "PGM5-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PGM5-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets